Vue transversale de la maladie
Myopathies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1012 résultats correspondants
· 46 visibles sur cette page
dans le périmètre Myopathies
Niveau clinique
Études et traitements 421
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Transcutaneous Spinal Stimulation (TSS) NCT05429736 · Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spa… | Myopathies | Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | For many people with spinal cord injury (SCI), the goal of walking is a hi… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:33 | Détail |
| AZD0530 Difumarate NCT04307953 · STOPFOP — Saracatinib Trial TO Prevent FOP | Myopathies | À vérifier | Phase 2 | ACTIVE_NOT_RECRUITING | This is a phase 2 study, designed as a European multicentre 6-month double… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| CABA-201 following preconditioning with fludarabine and cyclophospham… NCT06154252 · RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-… | Myopathies | Immunomodulation | Phase 2/3 | RECRUITING | RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CA… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Clinical evaluation NCT07792421 · NAP SAPS CSI — Pain Phenotype and Response to Corticosteroid Injection in Patien… | Myopathies | Traitement symptomatique | À vérifier | NOT_YET_RECRUITING | The goal of this prospective cohort study is to investigate whether pain p… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Clinical evaluation NCT07792434 · The NAP SAPS — Nociplastic Pain in Patients Diagnosed With Subacromial Pain Synd… | Myopathies | Traitement symptomatique | À vérifier | NOT_YET_RECRUITING | The goal of this prospective cohort study is to investigate whether pain p… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Effectiveness of Brief Mindfulness-Based Interventions for Painful Te… NCT06582134 · NCT06582134 | Myopathies | Traitement symptomatique · Thérapie génique | Non applicable | COMPLETED | The goal of this clinical trial is to learn if brief mindfulness-based int… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance… NCT06697717 · End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography… | Myopathies | À vérifier | Non applicable | COMPLETED | This study aims to adopt a randomized crossover design to compare the effe… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| GRASP-01-002 — Defining Endpoints in Becker Muscular Dystrophy NCT05257473 · NCT05257473 | Myopathies | À vérifier | À vérifier | ACTIVE_NOT_RECRUITING | This is a 24-month, observational study of 50 participants with Becker mus… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| INIT ART — Comparison of Integrated Neuromuscular Inhibition Techniqu… NCT07395154 · NCT07395154 | Myopathies | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | The goal of this clinical trial is to determine whether two manual therapy… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Monoplace Hyperbaric Chamber (Class III medical device). NCT06082518 · PCS-HBOT — Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments | Myopathies | Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | Over 500 million people have been infected with COVID-19, and to date, mor… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Piloting a Novel Peer Support Pain Self-Management Intervention (Proj… NCT04229134 · NCT04229134 | Myopathies | Traitement symptomatique · Thérapie génique | Non applicable | COMPLETED | The proposed study will test the feasibility and acceptability of an 8-wee… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Pulsed Electromagnetic Field Therapy NCT07802938 · Pulsed Electromagnetic Field Therapy Added to ESWT for Lateral Epicondylitis | Myopathies | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | This randomized, sham-controlled, assessor-blinded clinical trial will eva… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Resamirigene bilparvovec NCT03199469 · ASPIRO — A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (X… | Myopathies | Traitement symptomatique · Thérapie génique | Phase 2/3 | ACTIVE_NOT_RECRUITING | X-linked myotubular myopathy (XLMTM) is a rare and serious condition prese… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| SFL-0821 for injection NCT07798609 · A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and… | Myopathies | À vérifier | Phase 1/2 | NOT_YET_RECRUITING | The purpose of this study is to evaluate the safety, tolerability, and pre… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Triamcinolone injection to the shoulder, elbow, wrist, or hand NCT05292339 · Ketorolac in Upper Extremity Tendinopathy and Arthropathy | Myopathies | Immunomodulation · Traitement symptomatique | Phase 4 | RECRUITING | Osteoarthritis (OA) and inflammatory conditions of the tendons and joints… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| UX016 NCT07511556 · First-in-human Study of UX016 in GNEM | Myopathies | À vérifier | Phase 1/2 | RECRUITING | The goal of this study is to assess the safety and dose of UX016 and its i… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Whole body vibration therapy NCT07286435 · The Effect of Whole-Body Vibration Therapy Following Botulinum Toxin A Injection… | Myopathies | Traitement symptomatique | Non applicable | RECRUITING | The purpose of this clinical study is to evaluate the effect of Whole Body… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| zeleciment basivarsen (DYNE-101) NCT07486934 · Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Partic… | Myopathies | À vérifier | Phase 3 | RECRUITING | The purpose of the study is to assess the efficacy, safety, and tolerabili… À vérifier | ClinicalTrials.gov 2026-09-03 16:31:32 | Détail |
| Sham whole body vibration therapy Étude non communiquée | Myopathies | Traitement symptomatique | Non applicable | Actif | The purpose of this clinical study is to evaluate the effect of Whole Body… À vérifier | ClinicalTrials.gov 2026-09-02 | Détail |
| Shoulder orthosis Étude non communiquée | Myopathies · Sclérose latérale amyotrophique | Traitement symptomatique | Non applicable | Terminé | The goal of this clinical trial is to investigate the effect of a muscle-m… À vérifier | ClinicalTrials.gov 2026-09-02 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 585
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Perioperative Pregabalin for Recurrent Intractable Hiccups: A Case Re… baclofen · PMID 42436812 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Involuntary diaphragmatic spasms, "hiccups," commonly resolve spontaneously over a few minutes but can occasionally per… | Case reports in anesthesiology 2026-07-12 19:42:08 | Source |
| Novel pathological genetic variant associated with DOCK8 deficiency:… Fludarabine · PMID 42433063 | Myopathies | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source Deficiency of dedicator of cytokinesis 8 (DOCK8) is a combined immunodeficiency characterized by severe atopic dermatit… | Allergologia et immunopathologia 2026-07-12 19:42:02 | Source |
| Precision myeloablation with TDM-guided busulfan in pediatric primary… Fludarabine · PMID 42433921 | Myopathies | Thérapie cellulaire | Publication | PubMed | Voir la publication source Optimizing busulfan (Bu) exposure is critical for balancing engraftment and toxicity in pediatric patients with primary… | Translational pediatrics 2026-07-12 19:42:02 | Source |
| Dermatomyositis With Necrotizing Vasculitis, Pulmonary Arterial Hyper… Cyclophosphamide · PMID 42437258 | Myopathies | Ralentissement de la progression · Immunomodulation | Publication | PubMed | Voir la publication source Dermatomyositis is a rare autoimmune inflammatory disease with a highly heterogeneous clinical presentation and potenti… | Cureus 2026-07-12 19:41:40 | Source |
| Corrigendum to "Metformin prevents mandibular bone loss in a mouse mo… Metformin · PMID 42437281 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source [This corrects the article DOI: 10.1016/j.jot.2024.03.001.]. | Journal of orthopaedic translation 2026-07-12 19:41:27 | Source |
| Medicolegal autopsy reconstruction of a medication-related adverse ev… Metformin · PMID 42436565 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Adverse drug events are common in psychiatric inpatient care because polypharmacy is frequent and metabolic comorbiditi… | Journal of medical case reports 2026-07-12 19:41:27 | Source |
| Desipramine treatment disrupts phagocytic and intracellular survival… Desipramine · PMID 42211338 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source abortus is an intracellular pathogen that causes chronic infection and remains difficult to treat. In this study, desip… | Frontiers in veterinary science 2026-07-10 00:23:35 | Source |
| The efficacy and safety of hyoscyamine, dicyclomine, and desipramine… Desipramine · PMID 42381757 | Myopathies | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Patients with ileal pouch-anal anastomosis (IPAA) frequently experience high bowel frequency and abdominal pain that ar… | Crohn's & colitis 360 2026-07-10 00:23:35 | Source |
| [Efficacy of electroacupuncture nerve stimulation therapy for interst… Gentamicin infusions twice a week for six months · PMID 31099215 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source To explore the clinical efficacy of electroacupuncture nerve stimulation therapy (ENST) for interstitial cystitis/painf… | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 2026-07-10 00:23:34 | Source |
| FDA-approved antisense oligonucleotide therapies for duchenne muscula… Casimersen · PMID 42324661 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disorder caused by dystrophin deficiency. Antisense oli… | RNA biology 2026-07-10 00:23:33 | Source |
| RNA Therapeutics Targeting Skeletal Muscle: Emerging Antisense and Ge… Casimersen · PMID 42352260 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source RNA-based therapeutics are reshaping the treatment landscape for skeletal muscle disorders by enabling modulation of RN… | Biomolecules 2026-07-10 00:23:33 | Source |
| Adjuvant intravenous immunoglobulin in elderly sepsis: a randomized c… IvIg · PMID 42422830 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source Sepsis carries high mortality in older people, and immunomodulatory adjuncts to standard therapy are needed. To evaluat… | Frontiers in medicine 2026-07-10 00:23:32 | Source |
| Early postoperative onset of immune thrombocytopenia in rheumatoid ar… IvIg · PMID 42421261 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Immune thrombocytopenia (ITP) is often already recognised as a pre-existing comorbidity before surgery and managed with… | Modern rheumatology case reports 2026-07-10 00:23:32 | Source |
| Gestational deltamethrin exposure exacerbates post-traumatic epilepti… Behavioral Interventions for Controlling Oral Behaviors · PMID 42384231 | Myopathies | Neuroprotection | Publication | PubMed | Voir la publication source Gestational exposure to the neurotoxic insecticide deltamethrin (DLT) is suspected to increase susceptibility to neurol… | Metabolic brain disease 2026-07-10 00:23:31 | Source |
| Global, regional, and national burden of tuberculosis and multidrug-r… Behavioral Interventions for Controlling Oral Behaviors · PMID 42385762 | Myopathies | Ralentissement de la progression | Publication | PubMed | Voir la publication source Tuberculosis (TB) is the leading global cause of death from a single infectious agent. Recent reductions in global heal… | The Lancet. Infectious diseases 2026-07-10 00:23:31 | Source |
| Free functional muscle transfer after oncologic extremity reconstruct… Functional muscle transfer · PMID 42206261 | Myopathies | Ralentissement de la progression | Publication | PubMed | Voir la publication source Limb-salvage surgery for extremity sarcoma increasingly prioritizes preservation of meaningful motor function, yet onco… | JPRAS open 2026-07-10 00:23:29 | Source |
| Structural and Functional Principles in Quadriceps Reconstruction. Functional muscle transfer · PMID 42347482 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Quadriceps muscle and tendon injuries are a significant cause of impairment of the knee extensor mechanism, ranging fro… | Muscles (Basel, Switzerland) 2026-07-10 00:23:29 | Source |
| Chronic pain after mastectomy: current knowledge and knowledge gaps. Capsaicin Topical Cream · PMID 41733557 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Post-mastectomy pain syndrome (PMPS) is a frequent and burdensome complication of breast cancer surgery, manifesting as… | Minerva anestesiologica 2026-07-10 00:23:28 | Source |
| Non-Inferiority Study of Two Capsaicin Formulations for Painful Diabe… Capsaicin Topical Cream · PMID 41157180 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source While capsaicin topical formulations are established treatments, conventional creams using this substance have limited… | Life (Basel, Switzerland) 2026-07-10 00:23:28 | Source |
| Acute Myocardial Infarction Secondary to Idiopathic Ascending Aortic… Revascularization · PMID 42423567 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Ascending aortic thrombus causing acute myocardial infarction through coronary ostial occlusion is exceptional, with on… | JACC. Case reports 2026-07-10 00:23:21 | Source |
Exploration — prudence
Pistes exploratoires 6
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| N-PPG N-PPG — modulation métabolique cérébrale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Myopat… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| Vecteur Ple389 (ADORA2A) MiniPromoter Ple389 — ciblage striatal | Myopathies | Thérapie génique | Hypothèse exploratoire | Rapprochement automatique non validé | Expression génique ciblée dans les neurones striataux Vecteur Ple389 (ADORA2A) est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être per… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| α-Amyrin α-Amyrin — protection mitochondriale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Protection mitochondriale et modulation de la pathologie Tau α-Amyrin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour Myopa… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Myopathies | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| Thonningianin A Thonningianin A — neuroprotection anti-amyloïde | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation du stress oxydatif et des protéines associées à Alzheimer Thonningianin A est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| Vutiglabridin Vutiglabridin — autophagie et PON2 | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Activation de PON2 et stimulation de l’autophagie Vutiglabridin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |